Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.19.3
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 50,298 $ 56,399
Trading account assets, pledged as collateral 131,008 119,363
Debt securities:    
Held-to-maturity, fair value 194,274 200,435
Loans and leases, measured at fair value 7,674 4,349
Loans held-for-sale, measured at fair value 5,011 2,942
Other assets, measured at fair value 22,952 19,739
Deposits in U.S. offices:    
Interest-bearing, measured at fair value 626 492
Federal funds purchased and securities loaned or sold under agreements to repurchase, measured at fair value 21,963 28,875
Short-term borrowings, measured at fair value 3,458 1,648
Accrued expenses and other liabilities, measured at fair value 23,512 20,075
Accrued expenses and other liabilities, reserve for unfunded lending commitments 809 797
Long-term debt, measured at fair value $ 36,773 $ 27,689
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 3,895,685 3,843,140
Preferred stock outstanding (in shares) 3,895,685 3,843,140
Common stock par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 9,079,264,535 9,669,286,370
Common stock outstanding (in shares) 9,079,264,535 9,669,286,370
Consolidated VIEs | Long-term debt    
Shareholders’ equity    
Non-recourse debt $ 8,559 $ 10,943
Consolidated VIEs | Other liabilities    
Shareholders’ equity    
Non-recourse debt $ 23 $ 27